| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Rat |
| Host species | Mouse |
| Applications | IP,ICC,IF,Flow Cyt |
| Brand: | Abnova |
| Reference: | MAB6482 |
| Product name: | Plscr1 monoclonal antibody, clone 13A6 [TEC-23] |
| Product description: | Mouse monoclonal antibody raised against Plscr1. |
| Clone: | 13A6 [TEC-23] |
| Isotype: | IgG2a |
| Gene id: | 117540 |
| Gene name: | Plscr1 |
| Gene alias: | MGC93252 |
| Gene description: | phospholipid scramblase 1 |
| Immunogen: | BALB/c mice were immunized with pooled lipid rafts isolated from RBL-2H3 cells. Hybridoma cells were obtained after fusion of SP02 mouse myeloma cells with spleen cells of immunized mice using standard procedures. |
| Form: | Liquid |
| Recommend dilutions: | The optimal working dilution should be determined by the end user. |
| Storage buffer: | In ascites (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Rat |
| Specificity: | This antibody binds to rat Phospholipid Scramblase 1 (PLSCR1), an 37-49 KDa membrane-associated protein accelerating bidirectional movement of plasmamembrane phospholipids during conditions of elevated calcium. |
| Reactivity: | Rat |
| Application image: | ![]() |
| Application image note: | Immunofluorescence staining of Plscr1 in rat basophilic leukemia (RBL) cell line using Plscr1 monoclonal antibody, clone 13A6 [TEC-23] (Cat # MAB6482). |
| Applications: | IP,ICC,IF,Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1.Silverman RH, Halloum A, Zhou A, Dong B, Al-Zoghaibi F, Kushner D, Zhou Q, Zhao J, Wiedmer T, Sims PJ. Cancer Res. 2002 Jan 15;62(2):397-402. |